Results 1 to 10 of about 43,275 (138)

Canadian Physicians’ Use of Intramuscular Botulinum Toxin Injections for Shoulder Spasticity: A National Cross-Sectional Survey

Toxins, 2023
Spasticity of the upper extremity can result in severe pain, along with many complications that can impair a patient’s activities of daily living. Failure to treat patients with spasticity of the upper limb can result in a decrease in the range of motion
Farris Kassam, Brendan Lim, Sadia Afroz, Ève Boissonnault, Rajiv Reebye, Heather Finlayson, Paul Winston   +6 more
doaj   +1 more source

Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report

Case Reports in Neurology, 2021
Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic ...
Christian Avvantaggiato, Loredana Amoruso, Maria Pia Lo Muzio, Maria Assunta Mimmo, Michelina Delli Bergoli, Nicoletta Cinone, Luigi Santoro, Lucia Stuppiello, Antonio Turitto, Chiara Ciritella, Pietro Fiore, Andrea Santamato   +11 more
doaj   +1 more source

Surgical Approaches to Upper Limb Spasticity in Adult Patients: A Literature Review

Frontiers in Rehabilitation Sciences, 2021
Introduction: Spasticity is the main complication of many upper motor neuron disorders. Many studies describe neuro-orthopedic surgeries for the correction of joint and limb deformities due to spasticity, though less in the upper extremity.
Mahdis Hashemi, Mahdis Hashemi, Nadine Sturbois-Nachef, Nadine Sturbois-Nachef, Marry Ann Keenan, Marry Ann Keenan, Marry Ann Keenan, Paul Winston, Paul Winston, Paul Winston   +9 more
doaj   +1 more source

A Novel Approach to New-Onset Hemiplegic Shoulder Pain With Decreased Range of Motion Using Targeted Diagnostic Nerve Blocks: The ViVe Algorithm

Frontiers in Neurology, 2021
Introduction: Hemiplegic shoulder pain (HSP) is the most common pain disorder after stroke with incidence estimates of 30–70% and associated with reductions in function, interference with rehabilitation, and a reduced quality of life.
John W. Fitterer, Alessandro Picelli, Alessandro Picelli, Paul Winston, Paul Winston   +4 more
doaj   +1 more source

Canadian Physicians' Use of Perioperative Botulinum Toxin Injections to Spastic Limbs: A Cross-sectional National Survey

Archives of Rehabilitation Research and Clinical Translation, 2021
Objective: To investigate the practice patterns of Canadian physicians who use perioperative botulinum toxin (BoNT) injections to improve surgical outcomes on spastic limbs. Design: A cross-sectional national survey composed of an invitation email and an
Farris Kassam, BSc, Sepehr Saeidiborojeni, MD, Heather Finlayson, MD, FRCPC, Paul Winston, MD, FRCPC, Rajiv Reebye, MD, FRCPC   +4 more
doaj   +1 more source

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis

Toxins, 2022
Background: The present study aimed to evaluate the reasons and determinants of BoNT-A discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic brain injury.
Nicoletta Cinone, Luigi Santoro, Stefania Spina, Salvatore Facciorusso, Marco Battaglia, Alessio Baricich, Pasqua Marcogiuseppe, Andrea Santamato   +7 more
doaj   +1 more source

Rehabilitation interventions for glioma patients: a mini-review

Frontiers in Surgery, 2023
Glioma is a group of tumors that originate from glial cells within the central nervous system and comprise 27% of all tumors and 80% of malignant tumors.
Stefania Spina, Salvatore Facciorusso, Salvatore Facciorusso, Nicoletta Cinone, Raffaello Pellegrino, Pietro Fiore, Andrea Santamato   +6 more
doaj   +1 more source

High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients

Toxins, 2022
In the past few years, there was a great interest in the use of higher doses of botulinum toxin type A, especially in case of upper and lower limb severe spasticity. To date, only one prospective, non-randomized, single-arm, multicenter, open-label, dose-
Andrea Santamato
doaj   +1 more source

Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion

Toxins, 2021
Ultrasound (US)-guided botulinum neurotoxin (BoNT) injections are becoming a mainstay in the treatment of muscle spasticity in upper motor neuron syndromes.
Philippe Lagnau, Alto Lo, Ryan Sandarage, Katharine Alter, Alessandro Picelli, Jorg Wissel, Monica Verduzco-Gutierrez, Areerat Suputtitada, Michael C. Munin, Stefano Carda, Omar Khan, Serdar Koçer, Rajiv Reebye   +12 more
doaj   +1 more source

Quantitative assessment of spasticity: a narrative review of novel approaches and technologies

Frontiers in Neurology, 2023
Spasticity is a complex neurological disorder, causing significant physical disabilities and affecting patients' independence and quality of daily lives.
Jian He, Anhua Luo, Jiajia Yu, Chengxi Qian, Dongwei Liu, Meijin Hou, Meijin Hou, Ye Ma, Ye Ma, Ye Ma   +9 more
doaj   +1 more source